{"data":{"id":454,"citation":"Kimura Y, Aoki J, Kohno M, Ooka H, Tsuruo T, Nakanishi O.: P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel. Cancer Chemother Pharmacol, Volume 49 (4), 2002","title":"P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.","doi":"10.1007\/s00280-001-0419-x","doi_url":"https:\/\/doi.org\/10.1007\/s00280-001-0419-x","pmid":"11914912","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/11914912\/","year":2002,"journal":"Cancer Chemother Pharmacol","volume":"49","issue":"4","page":"322-328","authors":[{"first_name":"Aoki J","last_name":null,"full_name":null},{"first_name":"Kimura Y","last_name":null,"full_name":null},{"first_name":"Kohno M","last_name":null,"full_name":null},{"first_name":"Nakanishi O.","last_name":null,"full_name":null},{"first_name":"Ooka H","last_name":null,"full_name":null},{"first_name":"Tsuruo T","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/454","landing_page":"https:\/\/molmedb.upol.cz\/publication\/454","created_at":"2020-07-09T15:14:37.000000Z","updated_at":null}}